Company intelligence / Profile preview

frakktal

Houston, Texas, United Statesfrakktal.com ↗

Ownership: Private
Development stage: Other

Overview

frakktal is developing patent-pending, biobased polymers from lignocellulosic biomass, focusing on upcycling agricultural overages into durable materials for the built environment. The company has successfully manufactured these polymers at bench and pilot scale and is targeting markets such as building/construction (as PVC alternatives), automotive interiors, textiles/footwear, and biomedical applications. It is not a life science or healthcare company.

Industry: Non-Drug Biotech

Partnerships

gener8tor/HudsonAlpha Agtech Investment Accelerator

Beyond the preview

Go deeper on frakktal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on frakktal.

Explore the full profile